menu
    • menu

    Company profile for Siegfried AG

    Evonik

    Virtual Booth

    Contact Supplier

    Fishfa Biogenics: Renowned Manufacturer, & Exporter of Tacrolimus & Mupirocin API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    SERVICES

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    As an internationally renowned outsourcing partner, we offer products and tailor-made service packages that are seamlessly embedded in the value chain of our customers. Our pharmaceutical industry partners benefit from a wide range of offers - from the development of active ingredients to development services for ready-made drugs, their approval and production to packaging and logistics. As a former fully integrated pharmaceut...
    As an internationally renowned outsourcing partner, we offer products and tailor-made service packages that are seamlessly embedded in the value chain of our customers. Our pharmaceutical industry partners benefit from a wide range of offers - from the development of active ingredients to development services for ready-made drugs, their approval and production to packaging and logistics. As a former fully integrated pharmaceutical company, Siegfried is now one of the few suppliers who can develop both active ingredients and ready-made drugs under one roof. This combination of experience and know-how is unique in the CDMO market.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Siegfried AGSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Untere Bruehlstrasse 4, 4800 Zofingen
    Telephone
    Telephone
    +41 62 746 1111
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.siegfried.ch/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/siegfried-holding-ag
    youtube
    YouTube
    Twitter
    Twitter
    https://twitter.com/siegfried_group?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    CPhI India 2024

    CPhI India 2024

    Not Confirmed

    envelop Contact Supplier

    CPhI India 2024

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “Due to its 20-year mastery in micronization, Inke has emerged a cornerstone in treating global respiratory diseases”

    “Due to its 20-year mastery in micronization, Inke has emerged a cornerstone in treating global respiratory diseases”

    This week, SpeakPharma interviews Miquel Bachs, CEO of Inke, a company with over two decades of expertise in micronization and particle engineering, and a leader in providing high-quality, effective solutions in the global fight against chronic respiratory diseases such as COPD and asthma. In this insightful conversation, Bachs shares Inke’s strategic vision, technological innovations, and commitment to sustainability, offering a comprehensive look at how the company is shaping the future of respiratory health. HIGHLIGHTS// Inke’s strategic vision/ technological innovations/ commitment to sustainability Studies suggest that 13 percent of people over 40 years of age, the world over, have chronic obstructive pulmonary disease (COPD). Given the increasing prevalence of respiratory diseases, how does Inke position itself as a leader in the development and manufacturing of respiratory APIs? Inke has established itself as a global leader in generic respiratory API development through our unique blend  of technological innovation, expertise in micronization, and a comprehensive portfolio of inhalation therapies. With over 20 years of experience in micronization and particle engineering, our ability to customize APIs to meet specific client requirements has resulted in highly effective, high-quality products tailored for respiratory therapies. The increasing prevalence of chronic respiratory diseases, such as COPD and asthma, has only underscored Inke’s pivotal role in supporting the pharmaceutical industry’s need for advanced treatments. We specialize in bronchodilators and other critical respiratory APIs that improve patient outcomes and meet the stringent regulatory requirements of global health authorities. Our end-to-end approach, from early-stage API development to commercial-scale production, ensures that we maintain the highest standards of quality, safety, and efficacy. As the market for respiratory APIs continues to evolve, Inke remains committed to expanding its portfolio to address unmet therapeutic needs. Beyond respiratory APIs, we are also prioritizing growth in CNS treatments and building on our expertise in complex molecule synthesis. This strategic focus allows us to provide an integrated solution that not only meets current market demands but also anticipates future pharmaceutical trends. HIGHLIGHTS// comprehensive portfolio of inhalation therapies/ over 20 years of experience in micronization and particle engineering/ specialize in bronchodilators and other critical respiratory APIs/ prioritizing growth in CNS treatments In the field of micronization, what differentiates Inke’s approach from that of other manufacturers of respiratory APIs? What sets Inke apart in micronization is our advanced particle size reduction technology and our dedication to precision. Our facility is equipped with various milling techniques such as Cone, Jet, and Pin mills, allowing us to reduce particle size while stabilizing the amorphous content to ensure consistent quality. Our in-depth understanding of respiratory APIs, combined with our ability to tailor solutions for each customer, results in APIs with improved solubility, stability, and bioavailability, which are critical for the efficacy of inhalation products. This, along with our exceptional quality standards and a flawless audit track record, has positioned us as a key partner for major players in the inhalation market. HIGHLIGHTS// advanced particle size reduction technology/ technological innovations/ tailor solutions/ improved solubility, stability, and bioavailability Developing complex APIs can be challenging. How does Inke ensure a smooth and successful partnership throughout the development and manufacturing process, including customization, ensuring regulatory compliance and timely delivery? At Inke, we are dedicated to fostering strong partnerships with our clients through a collaborative approach that prioritizes open communication and mutual understanding. Our commitment to quality and personalized service sets us apart in the pharmaceutical landscape. Our team takes the time to engage in comprehensive discussions to customize our solutions, ensuring alignment with client specifications across all batches and grades. This commitment to flexibility allows us to respond effectively to evolving requirements, solidifying Inke’s reputation as a reliable partner. We understand that navigating regulatory landscapes can be challenging. That's why our team is equipped to manage all aspects of the regulatory process with meticulous attention to detail. From the submission of Drug Master Files (DMFs) and Certificates of Suitability to crafting precise responses to potential Deficiency Letters, we ensure compliance at every step. Moreover, we offer extensive support in patent and intellectual property matters, providing technical assistance and guidance tailored to the specific requirements of each region. Our unwavering dedication to quality, coupled with our agile response capabilities, enables us to deliver exceptional results while maintaining transparency and trust. At Inke, we are committed to building lasting relationships that drive success for both our clients and our organization. HIGHLIGHTS// ensuring alignment with client specifications/ manage all aspects of the regulatory process/ support in patent and intellectual property matters Given Inke’s global presence, what are the key markets for growth and how does Inke plan to expand its market reach and strengthen its position in these regions? Inke is strategically focused on expanding its footprint in the European and US markets, where we continue to prioritize our efforts. The US market remains pivotal for us, especially considering our successful FDA inspections and ongoing regulatory compliance efforts that solidify our reputation. Japan is another significant market where we have established a robust presence, reflecting our commitment to high-quality manufacturing and innovation. Looking ahead, China represents a key growth opportunity for Inke. With 12 active DMFs registered, we are well-positioned to tap into this burgeoning market. Our strategy involves leveraging our existing capabilities to navigate regulatory landscapes and fostering strong partnerships within the region, thereby enhancing our market reach and influence in the pharmaceutical sector. HIGHLIGHTS// expanding footprint in the European and US markets/ China represents a key growth opportunity for Inke With Inke expanding into contract manufacturing organization (CMO) services, how does this new offering align with Inke’s broader strategic goals, and what advantages does it provide to pharmaceutical partners? At Inke, the introduction of CMO services is a natural extension of our core expertise in the development and manufacturing of high-quality generic APIs. Our expansion into CMO is part of a strategic move to diversify our service portfolio, allowing us to offer end-to-end solutions for our clients. The CMO service integrates seamlessly with our expertise in API manufacturing, particularly in micronization, which has been a key differentiator for Inke for over two decades. With our advanced particle engineering capabilities, we can offer tailored solutions that meet specific technical and regulatory requirements. Whether it is small-batch production or scaling up to commercial quantities, we offer the flexibility to accommodate a wide range of customer needs. This adaptability, paired with our deep expertise in micronization, allows us to support evolving project needs, maintaining the highest standards of consistency, quality, and performance that define Inke’s footprint. HIGHLIGHTS// CMO is part of a strategic move to diversify our service portfolio/ deep expertise in micronization What is Inke’s commitment to sustainability and corporate social responsibility and how is it integrating sustainable practices into its operations and product development? At Inke, we recognize that integrating environmental, social, and governance (ESG) principles into our operations is not just a responsibility but a pathway to long-term success. Our ESG vision is centered around aligning business growth with sustainable practices that positively impact our communities and the environment. We are dedicated to environmental responsibility, actively implementing initiatives such as efficient wastewater treatment and water reuse systems to minimize our ecological footprint. Our recent investments in energy efficiency include the installation of a 135 kWp solar panel system, which underscores our commitment to reducing emissions and resource consumption across our manufacturing and research facilities. Inke is also committed to fostering a diverse and inclusive workforce. With a notable increase in our team members, particularly in operations and quality assurance, we prioritize career development and the well-being of our employees. By adhering to high regulatory standards, we ensure our products meet stringent global requirements, enhancing our transparency and compliance. Through these initiatives, Inke aims to cultivate sustainable practices that not only support our business objectives but also contribute positively to the pharmaceutical industry and society at large. HIGHLIGHTS// integrating ESG principles/ efficient wastewater treatment and water reuse systems/ installation of a 135 kWp solar panel system/ diverse and inclusive workforce

    Impressions: 405

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases

    #SpeakPharma With Inke
    28 Oct 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Drug Master Files, or DMFs, are confidential documents that play a crucial role in the pharmaceutical industry. These files, submitted to the US Food and Drug Administration (FDA), contain detailed information about ingredients, manufacturing processes, and packaging of medicines. They help the FDA oversee drug quality. Of the four types, Type II DMFs involve active pharmaceutical ingredients (APIs) for both branded and generic drugs. The third quarter (Q3) of 2024 saw Type II DMF submissions set a new record. A total of 309 Type II DMFs were submitted to the FDA during this period, a substantial 24.6 percent increase over Q3 2023 (with 248 submissions). The second quarter of 2024 too saw a remarkable increase, with 237 Type II DMFs being submitted compared to 178 in Q2 2023. View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available) China witnesses steep rise in DMF submissions, beats India with maximum filings In Q3 2024, China filed 153 DMFs submissions, marking a substantial 57.7 percent increase from the 97 submissions filed in Q3 2023. India maintained its strong position but fell to the number two spot with 110 DMFs, representing a modest 3.8 percent increase from 106 in Q3 2023. The US, which came a distant third, saw a slight decline in DMF submissions, with 13 filed in Q3 2024, as compared to 18 in Q3 2023. For several years, India had a lead in Type II DMFs. Since 2020, which marked the start of the pandemic, we have noticed a gradual increase in DMFs filed by China. This year, China has surpassed India considerably in the first three quarters. During the first nine months of 2024, China submitted 372, while India filed 286 DMFs. If this lead is maintained in Q4, DMFs from China will surpass that of India in 2024.  Amongst European countries, Spain led with seven DMFs, followed by Italy at four, and Germany and the Netherlands at three each. Among other nations, Japan contributed six while Israel submitted four DMFs. In company-wise tally, China’s Jiangsu East-Mab Biomedical Technology topped the list with an impressive 14 DMFs. On its heels were Indian companies — MSN at 13 DMFs, and Vamsi Labs and Hetero Drugs at nine DMFs each. China’s Porton Pharma and Wuxi AppTec filed five, while Shanghai Keze Yongxin Biotechnology, and Qingdao Glycogene Pharmaceutical contributed four submissions each. India's Maithri Drugs also submitted four. Japanese company Santeja filed five. Overall, Asia accounted for nearly 90 percent, with China contributing a dominant 49.5 percent of all DMF submissions. India was at 35.6 percent, the US at 4.2 percent, while Europe contributed 6.5 percent.  View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available) Diabetes, obesity, cancer, women’s health drugs emerge as hot molecules in Q3 2024 In terms of molecules, semaglutide (used for the treatment of type 2 diabetes and weight management) and relugolix (to treat prostate cancer and uterine fibroids) saw six DMF filings each in Q3 2024, indicating significant industry interest in these compounds. Following closely behind were semaglutide’s competitor tirzepatide and overactive bladder therapy vibegron, garnering four DMFs each. Finerenone (a non-steroidal drug for chronic kidney disease associated with type 2 diabetes) and voclosporin (an immunosuppressant for lupus nephritis) saw three DMFs each.  The last quarter also witnessed the introduction of 14 molecules with first-time DMFs. Among them were acetoxy empagliflozin, cabozantinib fumarate, tivozanib hydrochloride monohydrate, diosmetin, trilaciclib, clenbuterol hydrochloride, fenoterol hydrobromide, tapinarof and fezolinetant. Fezolinetant, with a DMF from Spain’s Moehs Iberica, is the active ingredient in Astellas’ Veozah, which is the first non-hormonal treatment for menopausal symptoms approved by the FDA. Tapinarof, filed by India’s Maithri Drugs, is used in Vtama, a novel steroid-free psoriasis cream. Other compounds that made their DMF debut include berotralstat, calcium phosphoryl choline chloride, phloroglucinol dihydrate, belumosudil mesylate and trimethylphloroglucinol. During Q2 2024, there were 19 drugs that saw DMF submissions for the first time, including molecules like triptorelin, sorafenib, pralsetinib, trilaciclib dihydrochloride, resmetirom (hepatology) and teneligliptin hydrochloride hydrate (metabolic disorders).  View FDA DMF Filings in Q3 2024 (Power BI Dashboard, Free Excel Available)    GDUFA fee for FY 2025: The FDA’s Generic Drug User Fee Amendments (GDUFA) is a law designed to speed access to safe and effective generic drugs to the public and reduce costs to the industry. The fiscal year 2025 fee rates were published on July 31, 2024. The FDA has revised fees under GDUFA III for all categories. While there is a slight increase in the DMF fee from US$ 94,682 in 2024 to US$ 95,084 in 2025, the ANDA fee has witnessed a significant jump — from US$ 252,453 in 2024 to US$ 321,920 in 2025. FY 2024 and FY 2025 User Fee Rates Generic drug fee category Fees rates for FY 2024 Fees rates for FY 2025 Applications: Abbreviated New Drug Application (ANDA) US$ 2,52,453   US$ 3,21,920   Drug Master File (DMF) US$ 94,682 US$ 95,084 Facilities: Active Pharmaceutical Ingredient (API)—Domestic US$ 40,464 US$ 41,580 API—Foreign US$ 55,464 US$ 56,580 Finished Dosage Form (FDF)—Domestic US$ 2,20,427   US$ 2,31,952 FDF—Foreign US$ 2,35,427   US$ 2,46,952 Contract Manufacturing Organization (CMO)—Domestic US$ 52,902 US$ 55,668 CMO—Foreign US$ 67,902 US$ 70,668 GDUFA Program: Large size operation generic drug applicant US$ 17,29,629   US$ 18,91,664 Medium size operation generic drug applicant US$ 6,91,852   US$ 7,56,666 Small business generic drug applicant US$ 1,72,963   US$ 1,89,166 Our view The highlight of the last few quarters has been the sharp rise in Type II DMF filings from China. The submission of a DMF is not required by law or any FDA regulation. FDA’s DMF guideline offers guidance on acceptable approaches to meeting regulatory requirements. Moreover, DMFs establish trust in APIs from lesser-known companies. With a growing emphasis on compliance and quality assurance, it appears that Chinese drug companies are eager to demonstrate their commitment to high standards and build trust in the US market. And that’s good news for the pharmaceutical industry.   
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 2483

    https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions

    #PharmaFlow by PHARMACOMPASS
    24 Oct 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Marcel Imwinkelried appointed as new CEO
    Marcel Imwinkelried appointed as new CEO

    10 Jul 2024

    // PRESS RELEASE

    https://www.siegfried.ch/marcel-imwinkelried-appointed-as-new-ceo/

    PRESS RELEASE
    10 Jul 2024
    Share Share
    Siegfried successfully completes acquisition of an early-phase CDMO in Wisconsin (US)
    Siegfried successfully completes acquisition of an early-phase CDMO in Wisconsin (US)

    02 Jul 2024

    // PRESS RELEASE

    Siegfried successfully completes acquisition of an early-phase CDMO in Wisconsin (US)

    PRESS RELEASE
    02 Jul 2024
    Share Share
    EGS's sexercises right to convert bond & increases its shareholding Siegfried
    EGS's sexercises right to convert bond & increases its shareholding Siegfried

    14 Jun 2024

    // PRESS RELEASE

    https://www.siegfried.ch/egs-beteiligungen-ag-exercises-right-to-convert-bond-and-increases-its-shareholding-in-siegfried-to-6-2-registered-shares/

    PRESS RELEASE
    14 Jun 2024
    Share Share
    Siegfried expands US reach with deal for Wisconsin facility
    Siegfried expands US reach with deal for Wisconsin facility

    13 Jun 2024

    // Joseph Keenan FIERCE PHARMA

    https://www.fiercepharma.com/manufacturing/cdmo-siegfried-expands-us-footprint-acquisition-wisconsin-facility

    Joseph Keenan FIERCE PHARMA
    13 Jun 2024
    Share Share
    Siegfried to acquire an early-phase CDMO in (US) for its Drug Sub services
    Siegfried to acquire an early-phase CDMO in (US) for its Drug Sub services

    12 Jun 2024

    // PRESS RELEASE

    https://www.siegfried.ch/siegfried-to-acquire-an-early-phase-cdmo-in-wisconsin-us-to-strengthen-its-drug-substances-service-offering/

    PRESS RELEASE
    12 Jun 2024
    Share Share
    Siegfried increases distribution to the shareholders & all proposals of the BOD
    Siegfried increases distribution to the shareholders & all proposals of the BOD

    15 Apr 2024

    // PRESS RELEASE

    https://www.siegfried.ch/siegfried-increases-distribution-to-the-shareholders-and-all-proposals-of-the-board-of-directors-are-approved/

    PRESS RELEASE
    15 Apr 2024
    Share Share

    ALL APIs

    read-moreClick the button for full data set
    read-moreClick the button for full data set

    01

    Buprenorphine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Buprenorphine

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down Click Us! arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-05-16

    Pay. Date : 2013-01-28

    DMF Number : 26052

    Submission : 2012-05-14

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2007-324 - Rev 01

    Issue Date : 2022-05-18

    Type : Chemical

    Substance Number : 1180

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 305MF10007

    Registrant's Address : Karlstrasse 15, 32423, Minden, Federal Republic of Germany

    Initial Date of Registration : 2023-01-18

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 0792-0631

    Start Marketing Date : 2015-02-27

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Caffeine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Caffeine

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2012-11-04

    Pay. Date : 2012-12-14

    DMF Number : 5032

    Submission : 1983-08-05

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1998-022 - Rev 03

    Issue Date : 2015-12-15

    Type : Chemical

    Substance Number : 267

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 217MF10988

    Registrant's Address : Karlstrasse 15, 32423, Minden, Federal Republic of Germany

    Initial Date of Registration : 2005-11-21

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 65724-4000

    Start Marketing Date : 2000-02-01

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF arrow-down
    ✖

    Registrant Name : CTC Bio Co., Ltd.

    Registration Date : 2022-08-08

    Registration Number : 20220808-211-J-1341

    Manufacturer Name : Siegfried PharmaChemikalien Minden GmbH

    Manufacturer Address : Karlstraße 15-39, 42-44 32423 Minden, Germany

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Dobutamine Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Dobutamine Hydrochloride

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 11023

    Submission : 1994-08-02

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2006-273 - Rev 01

    Issue Date : 2015-12-15

    Type : Chemical

    Substance Number : 1200

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 217MF10990

    Registrant's Address : Karlstrasse 15, 32423, Minden, Federal Republic of Germany

    Initial Date of Registration : 2005-11-21

    Latest Date of Registration :

    EU-WC NDC KDMF arrow-down
    ✖

    Registrant Name : CTC Bio Co., Ltd.

    Registration Date : 2021-11-23

    Registration Number : 20211123-210-J-1157

    Manufacturer Name : Siegfried PharmaChemikalien Minden GmbH

    Manufacturer Address : Karlstraße 15-39, 42-44 32423 Minden, Germany

     VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Dopamine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Dopamine

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 3116

    Submission : 1977-12-27

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2007-049 - Rev 01

    Issue Date : 2015-12-15

    Type : Chemical

    Substance Number : 664

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 218MF10519

    Registrant's Address : Karlstrasse 15, 32423, Minden, Federal Republic of Germany

    Initial Date of Registration : 2006-05-18

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 65724-4500

    Start Marketing Date : 2009-06-11

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Mepivacaine Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Mepivacaine Hydrochloride

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 3469

    Submission : 1979-01-10

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2001-305 - Rev 04

    Issue Date : 2018-11-08

    Type : Chemical

    Substance Number : 1242

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 218MF10524

    Registrant's Address : Route du Simplon 1,36,CH-1902 Evionnaz,Switzerland

    Initial Date of Registration : 2006-05-18

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 17381-261

    Start Marketing Date : 2010-04-15

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Oxybuprocaine Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Oxybuprocaine Hydrochloride

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 5024

    Submission : 1983-06-28

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R0-CEP 2022-104 - Rev 00

    Issue Date : 2023-08-31

    Type : Chemical

    Substance Number : 1251

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 304MF10112

    Registrant's Address : Route du Simplon 1,36,CH-1902 Evionnaz,Switzerland

    Initial Date of Registration : 2022-08-03

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 17381-253

    Start Marketing Date : 2010-05-11

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Prilocaine

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Prilocaine

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-03-19

    Pay. Date : 2013-08-13

    DMF Number : 14144

    Submission : 1999-05-12

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2002-227 - Rev 08

    Issue Date : 2021-02-24

    Type : Chemical

    Substance Number : 1362

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 222MF10085

    Registrant's Address : Route du Simplon 1,36,CH-1902 Evionnaz,Switzerland

    Initial Date of Registration : 2010-03-16

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 17381-017

    Start Marketing Date : 2010-04-22

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Prilocaine Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Prilocaine Hydrochloride

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2014-11-13

    Pay. Date : 2014-10-23

    DMF Number : 5019

    Submission : 1983-06-29

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 2002-170 - Rev 06

    Issue Date : 2021-02-24

    Type : Chemical

    Substance Number : 1363

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 219MF10013

    Registrant's Address : Route du Simplon 1,36,CH-1902 Evionnaz,Switzerland

    Initial Date of Registration : 2007-01-18

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 17381-249

    Start Marketing Date : 2010-04-22

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Primidone

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Primidone

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : Reviewed

    Rev. Date : 2023-03-28

    Pay. Date : 2023-03-23

    DMF Number : 2199

    Submission : 1973-12-07

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : R1-CEP 1996-101 - Rev 06

    Issue Date : 2020-02-07

    Type : Chemical

    Substance Number : 584

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 306MF10004

    Registrant's Address : No. 5, Tongshun Road, Nantong Economic & Technological Development Area, Nantong, Jiangsu Province, P. R. C.

    Initial Date of Registration : 2024-01-11

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 17205-307

    Start Marketing Date : 1973-12-07

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Tetracaine Hydrochloride

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    SupplySide West 2024
    Not Confirmed
    arrow

    Tetracaine Hydrochloride

    Switzerland

    USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

    arrow
    SupplySide West 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    USDMF arrow-down
    ✖

    GDUFA

    DMF Review : N/A

    Rev. Date :

    Pay. Date :

    DMF Number : 4065

    Submission : 1981-02-20

    Status : Active

    Type : II

     CEP/COS arrow-down
    ✖

    Certificate Number : CEP 2017-205 - Rev 01

    Issue Date : 2024-01-29

    Type : Chemical

    Substance Number : 57

    Status : Valid

     JDMF arrow-down
    ✖

    Registration Number : 220MF10198

    Registrant's Address : Route du Simplon 1,36,CH-1902 Evionnaz,Switzerland

    Initial Date of Registration : 2008-09-09

    Latest Date of Registration :

    EU-WC NDC arrow-down
    ✖

    NDC Package Code : 17381-100

    Start Marketing Date : 2010-05-18

    End Marketing Date : 2024-12-31

    Dosage Form (Strength) : POWDER (1kg/kg)

    Marketing Category : BULK INGREDIENT

    KDMF VMF Others AUDIT
    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    CEP/COS

    read-more
    read-more

    01

    Acemetacin

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    02

    Acemetacin, Code 100033

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    03

    Acemetacin, Polymorphic form II

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    04

    Amitriptyline hydrochloride

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    05

    Amorolfine hydrochloride

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    06

    Amorolfine hydrochloride, Nantong site

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    07

    Amylmetacresol

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    08

    Articaine hydrochloride

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    09

    Bupivacaine hydrochloride

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow

    10

    Buprenorphine

    CEP/COS

    SupplySide West 2024
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Services

    Upload your portfolio for free, ask us

    Analytical

    Click here to discover the service providers for Analytical

    API Manufacturing

    Click here to discover the service providers for API Manufacturing

    Drug Product Manufacturing

    Click here to discover the service providers for Drug Product Manufacturing

    Injectable / Parenteral

    read-more
    read-more

    01

    02

    03

    PRE-FILLED SYRINGES

    PRE-FILLED SYRINGES

    arrow
    SupplySide West 2024
    Not Confirmed

    04

    POWDER FOR INJECTION

    POWDER FOR INJECTION

    arrow
    SupplySide West 2024
    Not Confirmed

    05

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Packaging

    Click here to discover the service providers for Packaging

    API & Drug Product Development

    Click here to discover the service providers for API & Drug Product Development

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Siegfried AG and get a quotation

    Siegfried AG is a supplier offers 190 products (APIs, Excipients or Intermediates).

    Find a price of Buprenorphine bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Caffeine bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Dobutamine Hydrochloride bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Dopamine bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Mepivacaine Hydrochloride bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Nicotine bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Oxybuprocaine Hydrochloride bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Oxybutynin Hydrochloride bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Prilocaine bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Prilocaine Hydrochloride bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Primidone bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Tetracaine Hydrochloride bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Theophylline bulk with DMF, CEP, JDMF offered by Siegfried AG

    Find a price of Oxymetazoline Hydrochloride bulk with CEP, JDMF offered by Siegfried AG

    Find a price of Articaine Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Bupivacaine Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Buprenorphine bulk with DMF, CEP offered by Siegfried AG

    Find a price of Buprenorphine Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Carbachol bulk with DMF, CEP offered by Siegfried AG

    Find a price of Carbamazepine bulk with DMF, CEP offered by Siegfried AG

    Find a price of Fluoxetine Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Hydromorphone Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Isotretinoin bulk with DMF, CEP offered by Siegfried AG

    Find a price of Methadone Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Naloxone Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Naltrexone Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Nicotine bulk with DMF, CEP offered by Siegfried AG

    Find a price of Phenylephrine Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Pseudoephedrine Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Ribavirin bulk with DMF, JDMF offered by Siegfried AG

    Find a price of Theophylline bulk with DMF, CEP offered by Siegfried AG

    Find a price of Tretinoin bulk with DMF, CEP offered by Siegfried AG

    Find a price of Xylometazoline Hydrochloride bulk with DMF, CEP offered by Siegfried AG

    Find a price of Amitriptyline Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of Amorolfine Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of Fluoxetine Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of Methylphenidate Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of Morphine Sulfate bulk with CEP offered by Siegfried AG

    Find a price of Nifedipine bulk with CEP offered by Siegfried AG

    Find a price of Oxycodone Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of Selegiline Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of Sotalol Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Acemetacin bulk with CEP offered by Siegfried AG

    Find a price of Alitretinoin bulk with DMF offered by Siegfried AG

    Find a price of Aminophylline bulk with CEP offered by Siegfried AG

    Find a price of Amobarbital Sodium bulk with DMF offered by Siegfried AG

    Find a price of Amphetamine bulk with DMF offered by Siegfried AG

    Find a price of Amphetamine Aspartate bulk with DMF offered by Siegfried AG

    Find a price of Amylmetacresol bulk with CEP offered by Siegfried AG

    Find a price of Aprepitant bulk with JDMF offered by Siegfried AG

    Find a price of Benzonatate bulk with DMF offered by Siegfried AG

    Find a price of Bethanechol bulk with DMF offered by Siegfried AG

    Find a price of Bupivacaine bulk with DMF offered by Siegfried AG

    Find a price of Buprenorphine Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Butalbital bulk with DMF offered by Siegfried AG

    Find a price of Carbamazepine bulk with DMF offered by Siegfried AG

    Find a price of Carisoprodol bulk with DMF offered by Siegfried AG

    Find a price of Chlorobutanol Hemihydrate bulk with DMF offered by Siegfried AG

    Find a price of Chloroprocaine HCl bulk with DMF offered by Siegfried AG

    Find a price of Choline Salicylate bulk with DMF offered by Siegfried AG

    Find a price of Cinchocaine Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Codeine Phosphate bulk with DMF offered by Siegfried AG

    Find a price of Dexmethylphenidate bulk with DMF offered by Siegfried AG

    Find a price of Dextroamphetamine Saccharate bulk with DMF offered by Siegfried AG

    Find a price of Ephedrine bulk with DMF offered by Siegfried AG

    Find a price of Ephedrine Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of Ephedrine Sulfate bulk with DMF offered by Siegfried AG

    Find a price of Felbamate bulk with DMF offered by Siegfried AG

    Find a price of Fosinopril bulk with CEP offered by Siegfried AG

    Find a price of Hydrocodone Bitartrate bulk with DMF offered by Siegfried AG

    Find a price of Levomethadone bulk with CEP offered by Siegfried AG

    Find a price of Levonordefrin bulk with DMF offered by Siegfried AG

    Find a price of Mefloquine bulk with DMF offered by Siegfried AG

    Find a price of Methenamine Hippurate bulk with DMF offered by Siegfried AG

    Find a price of Metolazone bulk with DMF offered by Siegfried AG

    Find a price of Naloxone Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Nsc241225 bulk with JDMF offered by Siegfried AG

    Find a price of Oxiconazole Nitrate bulk with DMF offered by Siegfried AG

    Find a price of Oxybutynin bulk with DMF offered by Siegfried AG

    Find a price of Oxycodone Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Oxycodone Hydrochloride bulk offered by Siegfried AG

    Find a price of Oxymetazoline Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Phenelzine Sulfate bulk with DMF offered by Siegfried AG

    Find a price of Phenobarbital bulk with DMF offered by Siegfried AG

    Find a price of Phentermine Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Primidone bulk with JDMF offered by Siegfried AG

    Find a price of Proparacaine hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Ritalinic Acid bulk with DMF offered by Siegfried AG

    Find a price of Selegiline Hydrochloride bulk offered by Siegfried AG

    Find a price of Tetracaine bulk with CEP offered by Siegfried AG

    Find a price of Tetracaine Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Ticlopidine bulk with JDMF offered by Siegfried AG

    Find a price of Tilidine bulk with CEP offered by Siegfried AG

    Find a price of Topiramate bulk with JDMF offered by Siegfried AG

    Find a price of Trimethobenzamide HCl bulk with DMF offered by Siegfried AG

    Find a price of Venlafaxine Hydrochloride bulk with DMF offered by Siegfried AG

    Find a price of Xylometazoline Hydrochloride bulk with CEP offered by Siegfried AG

    Find a price of ENAMINE AMIDE bulk with DMF offered by Siegfried AG

    Find a price of Acetylcholine Chloride bulk offered by Siegfried AG

    Find a price of Acemetacin bulk offered by Siegfried AG

    Find a price of Allopurinol bulk offered by Siegfried AG

    Find a price of Alphacetylmethadol bulk offered by Siegfried AG

    Find a price of Amiloride Hydrochloride bulk offered by Siegfried AG

    Find a price of Apazone bulk offered by Siegfried AG

    Find a price of Benzomethamine bulk offered by Siegfried AG

    Find a price of Benzphetamine bulk offered by Siegfried AG

    Find a price of Bismuth Subsalicylate bulk offered by Siegfried AG

    Find a price of Candeptin bulk offered by Siegfried AG

    Find a price of Cascara bulk offered by Siegfried AG

    Find a price of Clopidogrel bulk offered by Siegfried AG

    Find a price of Codeine bulk offered by Siegfried AG

    Find a price of Codeine Sulfate bulk offered by Siegfried AG

    Find a price of Cyproheptadine Hydrochloride bulk offered by Siegfried AG

    Find a price of Deserpidine bulk offered by Siegfried AG

    Find a price of Desvenlafaxine Succinate bulk offered by Siegfried AG

    Find a price of Dextropropoxyphene bulk offered by Siegfried AG

    Find a price of Dextropropoxyphene HCl bulk offered by Siegfried AG

    Find a price of Dibenzosuberenone bulk offered by Siegfried AG

    Find a price of Dibenzsuberone bulk offered by Siegfried AG

    Find a price of Dihydrocodeine Tartrate bulk offered by Siegfried AG

    Find a price of Diltiazem Hydrochloride bulk offered by Siegfried AG

    Find a price of Diphenoxylate Hydrochloride bulk offered by Siegfried AG

    Find a price of Divalproex Sodium bulk offered by Siegfried AG

    Find a price of Gemfibrozil bulk offered by Siegfried AG

    Find a price of Glycopyrronium Bromide bulk offered by Siegfried AG

    Find a price of Gramicidin bulk offered by Siegfried AG

    Find a price of Hydralazine Hydrochloride bulk offered by Siegfried AG

    Find a price of Hydroxyzine Dihydrochloride bulk offered by Siegfried AG

    Find a price of Inositol niacinate bulk offered by Siegfried AG

    Find a price of Irbesartan bulk offered by Siegfried AG

    Find a price of Isoxsuprine Hydrochloride bulk offered by Siegfried AG

    Find a price of Khellin bulk offered by Siegfried AG

    Find a price of Mephenoxalone bulk offered by Siegfried AG

    Find a price of Mephobarbital bulk offered by Siegfried AG

    Find a price of Methacholine Chloride bulk offered by Siegfried AG

    Find a price of Metoprolol Tartrate bulk offered by Siegfried AG

    Find a price of Morphine Sulfate bulk offered by Siegfried AG

    Find a price of Narphen bulk offered by Siegfried AG

    Find a price of Neomycin bulk offered by Siegfried AG

    Find a price of Neomycin Sulfate bulk offered by Siegfried AG

    Find a price of Nimodipine bulk offered by Siegfried AG

    Find a price of Nitrendipine bulk offered by Siegfried AG

    Find a price of Omoconazole bulk offered by Siegfried AG

    Find a price of Oxcarbazepine bulk offered by Siegfried AG

    Find a price of Oxycodone Terephthalate bulk offered by Siegfried AG

    Find a price of Oxymorphone Hydrochloride bulk offered by Siegfried AG

    Find a price of Pethidine Hydrochloride bulk offered by Siegfried AG

    Find a price of Phenazopyridine bulk offered by Siegfried AG

    Find a price of Phenprobamate bulk offered by Siegfried AG

    Find a price of Pholcodine bulk offered by Siegfried AG

    Find a price of Propafenone Hydrochloride bulk offered by Siegfried AG

    Find a price of Propoxyphene Napsylate bulk offered by Siegfried AG

    Find a price of Quercetin bulk offered by Siegfried AG

    Find a price of Rescinnamine bulk offered by Siegfried AG

    Find a price of Reserpine bulk offered by Siegfried AG

    Find a price of Rutin bulk offered by Siegfried AG

    Find a price of SECOBARBITAL SODIUM bulk offered by Siegfried AG

    Find a price of Sodium Valproate bulk offered by Siegfried AG

    Find a price of Sulfiram bulk offered by Siegfried AG

    Find a price of Triamterene bulk offered by Siegfried AG

    Find a price of Tyrothricin bulk offered by Siegfried AG

    Find a price of Venlafaxine Hydrochloride bulk offered by Siegfried AG

    Find a price of Xipamide bulk offered by Siegfried AG

    Find a price of VERABORE--SPECIAL AMORPHOUS ALKALOIDS OF VERATRUM VIRIDE bulk offered by Siegfried AG

    Find a price of AMMOIDIN (8-METHOXYPSORALEN, XANTHATOXIN) bulk offered by Siegfried AG

    Find a price of ORGANIZATION MFG SITE BUILDING FACILITIES AND OPERATION OF FACTORY IN TAOYUAN TAIWAN ROC bulk offered by Siegfried AG

    Find a price of AQUEESTROL bulk offered by Siegfried AG

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN TAIPEI, TAIWAN. bulk offered by Siegfried AG

    Find a price of N-ACETYL PROCAINAMIDE HCL bulk offered by Siegfried AG

    Find a price of UTERASE bulk offered by Siegfried AG

    Find a price of PHTHALAMAQUIN bulk offered by Siegfried AG

    Find a price of OPIUM TINCTURE SOLUTION bulk offered by Siegfried AG

    Find a price of OPIUM TINCTURE, 2% bulk offered by Siegfried AG

    Find a price of RAUSERFIA TABLETS bulk offered by Siegfried AG

    Find a price of PROTAVERATRINE bulk offered by Siegfried AG

    Find a price of Atropine Sulfate bulk offered by Siegfried AG

    Find a price of Cyclizine bulk offered by Siegfried AG

    Find a price of Cyclizine Hydrochloride bulk offered by Siegfried AG

    Find a price of Lisdexamfetamine Dimesylate bulk offered by Siegfried AG

    Find a price of Metacaine bulk offered by Siegfried AG

    Find a price of Nalbuphine Hydrochloride bulk offered by Siegfried AG

    Find a price of Naltrexone bulk offered by Siegfried AG

    Find a price of Naltrexone Methobromide bulk offered by Siegfried AG

    Find a price of Nepafenac bulk offered by Siegfried AG

    Find a price of Phenobarbital Sodium bulk offered by Siegfried AG

    Find a price of Phentermine bulk offered by Siegfried AG

    Find a price of Pseudoephedrine bulk offered by Siegfried AG

    Find a price of Pseudoephedrine Sulfate bulk offered by Siegfried AG

    Find a price of Rimegepant Sulfate bulk offered by Siegfried AG

    Find a price of Travoprost bulk offered by Siegfried AG

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search